HRT Financial’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-267,951
Closed -$4.66M 4952
2026
Q1
$4.66M Buy
267,951
+245,169
+1,076% +$4.41M 0.01% 1045
2025
Q4
$397K Buy
+22,782
New +$371K ﹤0.01% 2230
2025
Q3
Sell
-156,775
Closed -$2.23M 3390
2025
Q2
$2.23M Sell
156,775
-2,500
-2% -$28.8K 0.01% 872
2025
Q1
$1.73M Sell
159,275
-21,464
-12% -$359K 0.01% 869
2024
Q4
$3.58M Buy
180,739
+87,120
+93% +$1.4M 0.02% 513
2024
Q3
$1.35M Buy
+93,619
New +$1.49M 0.01% 1070
2024
Q2
Sell
-11,391
Closed -$212K 2783
2024
Q1
$212K Sell
11,391
-45,331
-80% -$905K ﹤0.01% 1744
2023
Q4
$1.35M Buy
+56,722
New +$1.11M 0.01% 846
2023
Q1
Sell
-63,720
Closed -$2.16M 2942
2022
Q4
$2.16M Buy
+63,720
New +$2.16M 0.03% 553
2022
Q2
Sell
-12,218
Closed -$712K 3429
2022
Q1
$712K Buy
+12,218
New +$744K 0.01% 1369
2021
Q3
Sell
-20,099
Closed -$854K 3600
2021
Q2
$854K Buy
+20,099
New +$749K 0.01% 1240
2020
Q2
Sell
-19,841
Closed -$231K 1685
2020
Q1
$231K Buy
+19,841
New +$333K 0.01% 546

Other funds holding MXL

HRT Financial's MXL Position: Q2 2026 in Review

HRT Financial sold out of MaxLinear (MXL) in Q2 2026, closing a stake of 267,951 shares — an estimated $4.66M sold.

HRT Financial first reported a position in MXL in Q1 2020 and held it in 12 quarters. The position peaked at $4.66M in Q1 2026. 433 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

  • HRT Financial reported no remaining MaxLinear position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 267,951 MaxLinear shares in Q2 2026, an estimated $4.66M.
  • HRT Financial first reported a position in MaxLinear in Q1 2020 and held it in 12 quarters.
  • HRT Financial's MaxLinear position peaked at $4.66M in Q1 2026.
  • 433 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.